CLINICAL_TRIALS
trial_result
· 2017-08-28
Clinical Trial Update: Study of Dupilumab Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis [Phase 2]
Summary
A Phase 2 trial of dupilumab in adults with moderate-to-severe atopic dermatitis completed, with results posted in 2017.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Regeneron Pharmaceuticals | Conditions: Atopic Dermatitis | Phase 2 | Status: COMPLETED | Results posted: 2017-08-28